Rubius Therapeutics (STU:5RT) FCF Margin % : 0.00% (As of Dec. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rubius Therapeutics's Free Cash Flow for the three months ended in Dec. 2022 was €-30.95 Mil. Rubius Therapeutics's Revenue for the three months ended in Dec. 2022 was €0.00 Mil. Therefore, Rubius Therapeutics's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

As of today, Rubius Therapeutics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Rubius Therapeutics's FCF Margin % or its related term are showing as below:

STU:5RT's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -137.43
* Ranked among companies with meaningful FCF Margin % only.

Rubius Therapeutics FCF Margin % Historical Data

The historical data trend for Rubius Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rubius Therapeutics FCF Margin % Chart

Rubius Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

Rubius Therapeutics Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Rubius Therapeutics's FCF Margin %

For the Biotechnology subindustry, Rubius Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rubius Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rubius Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rubius Therapeutics's FCF Margin % falls into.

Rubius Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rubius Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-146.741	/	0
	=	%

Rubius Therapeutics's FCF Margin for the quarter that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2022 )	/	Revenue (Q: Dec. 2022 )
	=	-30.947	/	0
	=	%

Rubius Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Rubius Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rubius Therapeutics (STU:5RT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

124 Washington Street, Suite 101, Foxborough, MA, USA, 02035

Website

https://www.rubiustx.com

Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.

Rubius Therapeutics (STU:5RT) Headlines

No Headlines